Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) ROCE %: -12.85% (As of Dec. 2025)

What is Chunghwa Chemical Synthesis & Biotech Co ROCE %?

Chunghwa Chemical Synthesis & Biotech Co TPE:1762 58 ROCE % is -12.85% as of Dec. 2025. GuruFocus rates TPE:1762 with a GF Score™ of 58/100 and a GF Value™ of NT$37.92 (Fairly Valued). The stock has 8 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Chunghwa Chemical Synthesis & Biotech Co's annualized ROCE % for the quarter that ended in Dec. 2025 was -12.85%.

Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Chunghwa Chemical Synthesis & Biotech Co ROCE % Related Terms

Chunghwa Chemical Synthesis & Biotech Co ROCE % Historical Data

* Premium members only.

The historical data trend for Chunghwa Chemical Synthesis & Biotech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chunghwa Chemical Synthesis & Biotech Co ROCE % Chart

Chunghwa Chemical Synthesis & Biotech Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

15.43

15.41

8.51

1.81

-5.76

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
ROCE %	Get a 7-Day Free Trial															-0.22	0.81	-6.88	-4.50	-12.85

58GF Score

Chunghwa Chemical Synthesis & Biotech Co Ltd TPE:1762

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Chunghwa Chemical Synthesis & Biotech Co ROCE % Calculation

Chunghwa Chemical Synthesis & Biotech Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-238.946	/	( ( (4762.738 - 425.288)	+	(4317.353 - 356.706) )	/ 2 )
	=	-238.946	/	( (4337.45	+	3960.647)	/ 2 )
	=	-238.946	/	4149.0485
	=	-5.76 %

Chunghwa Chemical Synthesis & Biotech Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2025 )		(Q: Sep. 2025 )		(Q: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2025 )		(Q: Sep. 2025 )		(Q: Dec. 2025 )
	=	-517.12	/	( ( (4438.664 - 350.635)	+	(4317.353 - 356.706) )	/ 2 )
	=	-517.12	/	( ( 4088.029	+	3960.647 )	/ 2 )
	=	-517.12	/	4024.338
	=	-12.85 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -12.85% mean?

Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) has a ROCE % of -12.85% as of Dec. 2025.

Is Chunghwa Chemical Synthesis & Biotech Co's ROCE % too high?

Chunghwa Chemical Synthesis & Biotech Co's current ROCE % is -12.85%. Overall, Chunghwa Chemical Synthesis & Biotech Co has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Chunghwa Chemical Synthesis & Biotech Co's ROCE % compare to VRTX and REGN?

Chunghwa Chemical Synthesis & Biotech Co's ROCE % of -12.85% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Biotechnology company?

A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. Chunghwa Chemical Synthesis & Biotech Co's current ROCE % is -12.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Chunghwa Chemical Synthesis & Biotech Co stock overvalued right now?

Based on GuruFocus' analysis, Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) is currently considered Fairly Valued. The stock's GF Value™ is NT$37.92, compared to a current price of NT$38.15 — trading 0.6% above its estimated fair value. The current ROCE % is -12.85%. Chunghwa Chemical Synthesis & Biotech Co's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Chunghwa Chemical Synthesis & Biotech Co (TPE:1762), the current ROCE % is -12.85% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Overvalued in 2026?

Based on GuruFocus' analysis, Chunghwa Chemical Synthesis & Biotech Co stock appears to be overvalued. The current stock price of NT$38.15 is trading 0.6% above its estimated GF Value™ of NT$37.92. GuruFocus considers Chunghwa Chemical Synthesis & Biotech Co to be Fairly Valued.

Key valuation signals for TPE:1762:

ROCE %: -12.85%
GF Value™: NT$37.92 vs. price of NT$38.15 (0.6% above fair value)
GF Score™: 58/100 with 8 warning signs

No single metric tells the full story. See the TPE:1762 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chunghwa Chemical Synthesis & Biotech Co Business Description

Industry Healthcare Biotechnology

Comparable Companies ROCO:4168 TPE:6885 TPE:1733 ROCO:6461 ROCO:6892 ROCO:6808 TPE:6657 ROCO:6986 ROCO:7808 ROCO:8279 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address No. 1, Dongxing Street, Shulin District, Taipei, TWN

Website http://www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in the research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of its revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises pain management, antifungal, immunosuppressant, oncology, Cardiovascular, Peptide Drugs, and Others.

58GF Score

Get the complete analysis for TPE:1762

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.15

Price

NT$37.92

GF Value

View TPE:1762 Analysis

See ROCE % data for all stocks →